Alzheimer's trial disappointing but yields new ideas

A new study in the New England Journal of Medicine documents the high-profile failure of a promising drug, bapineuzumab, to slow cognitive decline in dementia patients. Dr. Stephen Salloway, the study’s lead author, says researchers have learned key lessons that they are eager to apply in new attempts to find Read & Research Alzheimer’s More

Leave a Reply